Yazar "Ozansoy, Mehmet" için PubMed İndeksli Yayınlar Koleksiyonu listeleme
-
The association between Hba1c levels, olfactory memory and cognition in normal, pre-diabetic and diabetic persons
Yuluğ, Burak; Saatçi, Özlem; Işıklar, Aysun; Hanoğlu, Lütfü; Kılıç, Ulkan; Ozansoy, Mehmet; Kılıç, Ertuğrul (Bentham Science Publishers, 2020)Background and Aim: Recent data have shown that olfactory dysfunction is strongly related to Alzheimer’s Disease (AD) that is often preceded by olfactory deficits suggesting that olfactory dysfunction might represent an ... -
Melatonin affects the release of exosomes and tau-content in in vitro amyloid-beta toxicity model
Ozansoy, Mehmet; Ozansoy, Muzaffer Beyza; Yuluğ, Burak; Çankaya,Şeyda; Kılıç, Ertuğrul; Göktekin, Şule; Kılıç, Ülkan (Churchill Livingstone, 2020)Background: Recent studies have been revealed that oxidative damage is the main cause of aging and age-related neurodegenerative diseases like Alzheimer's disease (AD). Melatonin is secreted from the pineal gland and its ... -
Minocycline increases in-vitro cortical neuronal cell survival after laser induced axotomy
Yuluğ, Burak; Ozansoy, Mehmet; Alökten, Merve; Ozansoy, Muzaffer; Çankaya, Şeyda; Hanoğlu, Lütfü; Kılıç, Ertuğrul (Bentham Science Publ Ltd, 2020)Background: Antibiotic therapies targeting multiple regenerative mechanisms have the potential for neuroprotective effects, but the diversity of experimental strategies and analyses of non-standardised therapeutic trials ... -
Role of erythropoietin and its receptor in the development of endometriosis in rats
Günal, Mehmet Yalçın; Ozansoy, Mehmet; Kılıç, Ülkan; Keskin, İlknur; Özdemir, Ekrem Musa; Aslan, İsmail; Kılıç, Ertuğrul (2019)Objective: Besides its hematopoietic function, erythropoietin (EPO) may protect tissues from degenerative disorders. As such, EPO and its receptors were revealed in nonhematopoietic cells, including stromal and endometrial ... -
Squalene attenuates the oxidative stress and activates AKT/mTOR pathway against cisplatin-induced kidney damage in mice
Sakul, Arzu; Ozansoy, Mehmet; Elibol, Birsen; Ayla, Şule; Günal, Mehmet Yalçın; Yozgat, Yasemin; Kılıç, Ülkan (2019)The clinical use of cisplatin, which is a first-line anticancer agent, is highly restricted due to its adverse effects on kidneys that lead to nephrotoxicity. Therefore, some potential reno-protective substances have been ...